RESEARCH PAPER
Stroke epidemiology based on experience from Krasnik county in eastern Poland
More details
Hide details
1
Department of Informatics and Medical Statistics, Faculty of Health Sciences, Medical University, Lublin, Poland
2
II Faculty of Medicine of the English Division, Department of Public Health, Medical University, Lublin, Poland
Corresponding author
Marek Kos
II Faculty of Medicine of the English Division, Department of Public Health, Medical University, Lublin, Poland
Ann Agric Environ Med. 2020;27(3):448-455
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Cerebrovascular diseases in Poland constitute a bigger threat to life in men than in women, especially after the age of 60. Death rates indicate higher stroke over-mortality in the rural population rather than the urban. At the same time, stroke is the main cause of long-term disability, since half of the patients are unable to independently perform daily activities, which makes them dependent on other people.
Material and methods:
The study was conducted in the Independent Public Healthcare Institution in Kraśnik, eastern Poland. It covered the medical records of 1,500 patients, 780 women (52%) and 720 men (48%), aged 20–100, diagnosed with cerebral infarction. The patients were hospitalised between 2011–2016 in the Neurology Ward with a Stroke Unit, the Internal Medicine Ward, and the Anaesthetics and Intensive Care Ward.
Results:
The stroke patients hospitalised in the Independent Public Healthcare Institution in Kraśnik were residents of urban communes (59.1% of subjects) and rural communes (40.9%). The most often diagnosed type of stroke was due to embolism of the cerebral arteries (I63.4) in women (63.48%). In men, the most most often diagnosed type was cerebral infarction due to thrombosis of the cerebral arteries (I63.3; 51.33%). Stroke in 36.15% of the female subjects resulted in death. In male subjects, death occurred in 26.11% of the cases.
Conclusions:
Women aged around 78-years-old were the most likely to suffer a stroke. In men, it occurred eight years earlier. Despite residents of urban areas being hospitalised due to stroke more often, deaths caused by this disease were recorded the most frequently among rural residents. It can be concluded that primary stroke prevention is the only effective measure for reducing morbidity and premature mortality in the population.
REFERENCES (76)
1.
Cendrowski W. Epidemiologia naczyniowych udarów mózgu [Epidemiology of cerebrovascular accidents] (in:) Udary naczyniowe mózgu diagnostyka i leczenie [Cerebrovascular accidents – diagnosis and treatment], ed. J. Majkowski, Wydawnictwo Lekarskie PZWL, Warsaw 1998, 14. (in Polish).
2.
Słowik A, Wnuk M, Dziedzic T, Pera J. Niedokrwienny udar mózgu. Choroby naczyniowe układu nerwowego [Ischemic stroke. Vascular diseases of the nervous system] (in:) Neurologia. Kompendium [Neurology. A compendium], ed. Kozubski W. PZWL, 1st edition, Warsaw 2014, 309, 310, 315–317. (in Polish).
3.
Sorensen AG, Ay H. Transient ischemic attack: definition, diagnosis, and risk stratification, Neuroimaging Clin N Am. 2011; 21(2): 303–313.
4.
Robbins NM, Swanson RA. Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism. Stroke. 2014; 45(6): 1881–6.
5.
Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008; 14(5): 497–500.
6.
Słowik A, Wnuk M, Dziedzic T, Pera J. Niedokrwienny udar mózgu. Choroby naczyniowe układu nerwowego [Ischemic stroke. Vascular diseases of the nervous system] (in:) Neurologia. Podręcznik dla studentów medycyny [Neurology. A course book for medicine students] eds. Kozubski W, Liberski P, PZWL, Vol. 2, Warsaw 2013, 475, 473, 474, 483–485. (in Polish).
7.
Prusiński A. Neurologia praktyczna [Practical neurology], 3rd edition, Wydawnictwo Lekarskie PZWL, Warsaw 2005, 209–211. (in Polish).
8.
Mazur R, Książkiewicz B. Symptomatologia kliniczna ostrych udarów naczyniowych mózgu [Clinical symptomatology of acute cerebrovascular accidents] (in:) Udary naczyniowe mózgu diagnostyka i leczenie [Cerebrovascular accidents – diagnosis and treatment] ed. J. Majkowski, Wydawnictwo Lekarskie PZWL, Warsaw 1998, 28. (in Polish).
9.
Głuszek J. Czynniki ryzyka udaru mózgu i prewencja pierwotna [Stroke risk factors and preliminary prevention] (in:) Życie po udarze w podejściu holistycznym [A holistic approach to life after a stroke], ed. J. Twardowska-Rajewicz, Publishing Press of the Adam Mickiewicz University, Poznań 2010, 37–43. (in Polish).
10.
Chalmers J, MacMahon S, Anderson C, Neal B, Rodgers A. Ciśnienie tętnicze a udar mózgowy. Poradnik klinicysty [Blood pressure and stroke. A clinician’s guidebook], Via Medica, Gdańsk 1996, 14–16. (in Polish).
11.
Raport z ogólnopolskiego badania ankietowego na temat postaw wobec palenia tytoniu [A report on the Polish nation-wide questionnaire survey on attitudes to tobacco smoking], TNS Polska for the Chief Sanitary Inspectorate, Warsaw 2015. (in Polish).
12.
Levine DA, Wadley VG, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Howard G, Howard VJ, Cushman M, Judd SE, Galecki AT. Risk Factors for Poststroke Cognitive Decline The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke). Stroke. 2018; 49: 987–994.
13.
Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva, World Health Organization; 2018,
http://www.who.int/en/news-roo....
14.
Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–1757.
15.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman, M, et al. Heart disease and stroke statistics—2016 update a report from the american heart association. Circulation. 2015; 133: e38–360.
16.
Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J. 2013; 34(4): 268–277.
17.
Health at a Glance: Europe 2016 – State of Health in the EU Cycle, OECD/EU, Paris 2016.
19.
Della-Morte D, Guadagni F, Palmirotta R, et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics. 2012; 13(5): 595–613.
20.
Bourgeais V. Causes of death in 2013. Over a million persons died in the EU from a heart attack or a stroke. Cause of 1 in every 5 deaths in the EU, Eurostat Press Office, 91/2016 – May 2016,
http://ec.europa.eu/eurostat/d....
21.
Sytuacja zdrowotna ludności Polski i jej uwarunkowania [The health status of the Polish population and its determinants], eds. B. Wojtyniak, P. Goryński. The National Institute of Public Health – National Institute of Hygiene, Warsaw 2016 (in Polish).
22.
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision, Vol. I, issue 2008, WHO, pp. 326–327.
23.
Ludność w 2016 roku w powiecie kraśnickim [Population in 2016 in the Kraśnik District], Statistics Poland, Branch in Lublin,
http://lublin.stat.gov.pl/file... (in Polish).
24.
Armitage P. Metody statystyczne w badaniach medycznych [Statistical methods in medical studies]. PZWL Warsaw 1978. (in Polish).
25.
Sawicki F.: Elementy statystyki dla lekarzy [Elements of statistics for medical doctors]. PZWL Warsaw 1982. (in Polish).
26.
Przygotowanie szpitali do leczenia pacjentów z udarem mózgu. Raport Najwyższej Izby Kontroli [Readiness of hospitals for treating stroke patients. The Supreme Chamber of Control’s Report]. Warsaw 2016: 7. (in Polish).
27.
Udary mózgu – konsekwencje społeczne i ekonomiczne [Strokes – social and economic consequences], ed. M. Gałązka-Sobotka, Lazarski University, Warsaw 2013; (in Polish).
28.
Ingeman A, Andersen G, Thomsen RW, Hundborg HH, Rasmussen HH, Johnsen SP. Lifestyle Factors and Early Clinical Outcome in Patients With Acute Stroke A Population-Based Study, Stroke. 2017; 48: 611–617.
29.
Zdrowie i zachowanie zdrowotne mieszkańców Polski w świetle Europejskiego Ankietowego Badania Zdrowia (EHIS) 2014 [Health and health-related behaviors of people living in Poland in the light of the European Health Interview Survey (EHIS) 2014], Statistics Poland, Warsaw 2015, 6–7.
30.
Andersen KK, Olsen TS. The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke. 2015; 10(1): 99–104.
31.
Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR. The impact of obesity on urinary tract infection risk. Urology. 2012; 79: 266–269.
32.
Olsen TS, Dehlendorff C, Petersen HG, Andersen KK. Body mass index and poststroke mortality. Neuroepidemiol. 2008; 30: 93–100.
34.
Policy paper dla ochrony zdrowia na lata 2014–2020. Krajowe ramy strategiczne. Narodowa Strategia Spójności [Policy paper for health protection for 2014–2020. The National Strategic Framework. The National Cohesion Strategy], Warsaw 2014, 34–35. (in Polish).
35.
Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T, et al. Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke. 2011; 42: 30–36.
36.
Jing J, Pan Y, Zhao X, et al. Prognosis of Ischemic Stroke With Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria in Chinese Population. Stroke. 2016; 47: 2038–2044.
37.
Smith EE, Shobha N, Dai D, Olson DM, Reeves MJ, Saver JL, et al. Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With The Guidelines-Stroke Program. Circulation. 2010; 122: 1496–1504.
38.
Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart ssociation/American Stroke Association. Stroke. 2011; 42: 227–276.
39.
Boan AD, Lackland DT, Ovbiagele B. Lowering of blood pressure for recurrent stroke prevention. Stroke. 2014; 45: 2506–2513.
40.
Kunst AE, Amiri M, Janssen F. The decline in stroke mortality: exploration of future trends in 7 Western European countries. Stroke 2011; 42: 2126–30.
41.
Burke SN, Barnes CA. Neural plasticity in the ageing brain, Nat Rev Neurosci. 2006; l(7): 30–40.
42.
Park DC, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol. 2009; 60: 173–196.
43.
Reuter-Lorenz PA, Park DC. How does it STAC up? Revisiting the scaffolding theory of aging and cognition. Neuropsychol Rev. 2014; 24: 355–370.
44.
„Prognoza ludności na lata 2008–2035” [Population forecast for 2008–2035], Statistics Poland, Warsaw 2009, pp. 308–310. (in Polish).
45.
Winovich DT, Longstreth WT, Arnold AM, Varadhan R, Al Hazzouri AZ, et al. Factors Associated With Ischemic Stroke Survival and Recovery in Older Adults, Stroke, 2017; 48: 1818–1826. (in Polish).
46.
Postępowanie w Ostrym Udarze Niedokrwiennym Mózgu: Raport zespołu ekspertów Narodowego Programu Profilaktyki i Leczenia Udaru Mózgu [Procedures taken in acute ischemic stroke cases: A report of an expert group as part of the National Stroke Prevention and Treatment Programme]. Neurol Neurochir Pol. 1999; 33(4): 13–60.
47.
Aboderin I, Venables G. Stroke management in Europe. Pan European Consensus Meeting on Stroke Management. J Intern Med. 1996; 240: 173–180.
48.
Kwolek A. Historia rehabilitacji neurologicznej w Polsce [The history of neurological rehabilitation in Poland]. In: Jandziś S, Kwolek A. Rozwój rehabilitacji w wybranych specjalnościach medycznych w Polsce [Rehabilitation development in selected medical specializations in Poland]. Rzeszów, Publishing House of the University of Rzeszów 2014; 109–132. (in Polish).
49.
Fischer U, de Sousa D, Norrving B, Caso V. Status and Perspectives of Acute Stroke Care in Europe. Stroke. 2018; 49: 2281–2282.
50.
,,Program Profilaktyki i Leczenia Chorób Układu Sercowo-Naczyniowego POLKARD na lata 2017–2020’’ [The National Programme for Prevention and Treatment of Cardiovascular Diseases POLKARD for 2017–2020], Ministry of Health, Warsaw 2017, 18–19.
https://www.gov.pl/zdrowie/pro.... (in Polish).
51.
Arnao V, Popovic N, Caso V. How is stroke care organized in Europe? Press Med. 2016; 45: 399–408.
52.
„Ogólnopolski Program Profilaktyki Chorób Naczyń Mózgowych (ICD 10:I60-I69)’’ na lata 2017–2020, opracowany i współfinansowany ze środków Unii Europejskiej w ramach Programu Operacyjnego Wiedza Edukacja Rozwój [The National Stroke Prevention and Treatment Programme (ICD 10:I60-I69) for 2017–2020, developed and co-financed from EU resources as part of the Knowledge, Education, Development Operational Programme], pp. 4–5. (in Polish).
53.
Di Carlo A, Pezzella FR, Fraser A, MA; Bovis F, Baeza J, McKevitt Ch, BoazA, Heuschmann P, Wolfe ChDA, Inzitari D. Methods of Implementation of Evidence-Based Stroke Care in Europe. European Implementation Score Collaboration. Stroke. 2015; 46: 2252–2259.
55.
Norrving B. The 2006 Helsingborg Consensus Conference on European Stroke Strategies: Summary of conference proceedings and background to the 2nd Helsingborg Declaration. Int J Stroke 2007; 2: 139–43.
56.
Wiszniewska M, Kobayashi A, Członkowska A. Postępowanie w udarze mózgu Skrót Wytycznych Grupy Ekspertów Sekcji Chorób Naczyniowych Polskiego Towarzystwa Neurologicznego z 2012 roku [Procedures taken in stroke cases. Abbreviated guidelines of an Expert Group of the Vascular Diseases Section of the Polish Neurological Society developed in 2012], Polski Przegląd Neurologiczny [The Polish Neurological Review], 2012; 8(4): 161–175. (in Polish).
57.
Liang J, Gao P, Lin Y, Song H, Sui QB. Susceptibility-weighted imaging in post-treatment evaluation in the early stage in patients with acute ischemic stroke. J Inter Med Res. 2019; 47(1): 196–205.
58.
Łabuz-Roszak B, Starostka-Tatar A, Lasek-Bal A, Gierlotka M, Gąsior M, Skrzypek M. Diagnostics, treatment and secondary prevention of ischemic stroke in the Silesian Province, Poland between 2009 and 2015. Neurologia i Neurochirurgia Polska [Polish Neurology and Neurosurgery], 2018; 52(2): 235–242. (in Polish).
59.
Khatib R, Jawaada AM, Arevalo YA, Hamed HK, Mohammed SH, Huffman MD. Implementing Evidence-Based Practices for Acute Stroke Care in Low- and Middle-Income Countries. Curr Atheroscler Rep. 2017; 19(12).
60.
Gache K, Leleu H, Nitenberg G, Woimant F, Ferrua M, Minvielle E. Main barriers to effective implementation of stroke care pathways in France: a qualitative study, BMC Health Serv Res. 2014; 28(14).
61.
Członkowska A, Milewska D, Ryglewicz D. The Polish experience in early stroke care. Cerebrovasc Dis. 2003; 15(1): 14–15.
62.
Kaczorowski R, Murjas B, Bartosik-Psujek H. Rozwój i nowe perspektywy leczenia udarów mózgu w Polsce [Advancements and new perspectives in stroke treatment in Poland]. Med Rev. 2015; 13(4): 376–386. (in Polish).
63.
Armstrong MJ. Shared decision-making in stroke: an evolving approach to improved patient care. Stroke Vasc Neurol, 2017; 2(2): 84–87.
64.
Smajlović D. Strokes in young adults: epidemiology and prevention, Vascular Health and Risk Management 2015; 11: 157–164.
65.
Castilla-Guerra L, Fernandez-Morenoa MC. Chronic Management of Hypertension after Stroke: The Role of Ambulatory Blood Pressure Monitoring. J Stroke. 2016; 18(1): 31–37.
66.
De HavenonA, Bennett A, Stoddard GJ, Smith G, Chung L, O’Donnell S, McNally JS, Tirschwell D, Majersik JJ. Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke. Stroke Vascular Neurol. 2017; 2(1): 1–6.
67.
Appleton JP, Sprigg N, Bath PM. Blood pressure management in acute stroke, Stroke Vasc Neurol. 2016; 1(2): 72–82.
68.
Kapral MK, Laupacis A, Phillips SJ, et al. Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke. 2004; 35(7): 1756–1762.
69.
Brittain KR, Shaw C. The social consequences of living with and dealing with incontinence--a carers perspective. Soc Sci Med. 2007; 65(6): 1274–1283.
70.
Litwin T, Członkowska A. Udary mózgu – wprowadzenie [Strokes – An introduction]. In: Stępień A. (ed.). Neurologia [Neurology], Warsaw, Medical Tribune Polska 2014; 2: 171–188. (in Polish).
71.
Litwin T, Członkowska A. Ostre niedokrwienie mózgu – udar niedokrwienny i przemijające niedokrwienie mózgu [Acute cerebral ischemia – ischemic stroke and temporary cerebral ischemia]. In: Stępień A. (ed.) Neurologia [Neurology], Warsaw, Medical Tribune Polska 2014; 2: 189–215. (in Polish).
72.
Kronish IM, Goldfinger JZ, Negron R, Fei K, Tuhrim S, Arniella G, Horowitz CR. Effect of Peer Education on Stroke Prevention The Prevent Recurrence of All Inner-City Strokes Through Education Randomized Controlled Trial. Stroke. 2014; 45: 3330–3336.
73.
Kissela BM, Khoury JC, Alwell K, et al. Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology. 2012; 79(17): 1781–1887.
74.
Chwojnicki K, Ryglewicz D, Wojtyniak B, Zagożdżon P, Członkowska A, Jędrzejczyk T, Karaszewski B, Kozera G, Gierlotka M, Ezzati M, Zdrojewski T. Acute Ischemic Stroke Hospital Admissions, Treatment, and Outcomes in Poland in 2009–2013. Front Neurol. 2018; 9: 134.
75.
Mu F, Hurley D, Betts KA, et al. Real-world costs of ischemic stroke by discharge status. Curr Med Res Opin. 2017; 33(2): 371–378.
76.
Heuschmann PU, Wiedmann S, Wellwood I, Rudd A, Di Carlo A, Bejot Y, Ryglewicz D, Rastenyte D, Wolfe CD. European Registers of Stroke. Three-month stroke outcome: the European Registers of Stroke (EROS) investigators. Neurology. 2011; 76: 159–165.